公开(公告)号：US12082794B2

公开(公告)日：2024-09-10

申请号：US16136674

申请日：2018-09-20

Applicant: BOSTON SCIENTIFIC SCIMED, INC.

Inventor： David John Onushko ,  Jose A. Meregotte ,  Steven R. Larsen

IPC: A61B17/00 ,  A61B17/12 ,  A61B90/00

CPC classification number: A61B17/0057 ,  A61B17/12122 ,  A61B17/12172 ,  A61B17/12177 ,  A61B2017/00526 ,  A61B2017/00867 ,  A61B2017/00893 ,  A61B2017/1205 ,  A61B17/12109 ,  A61B2090/3966

Abstract: An example occlusive implant is disclosed. The example occlusive implant includes an expandable framework configured to shift between a collapsed configuration and an expanded configuration, an occlusive member disposed along at least a portion of the expandable framework and a sealing member disposed along the occlusive member.

公开(公告)号：US20240293135A1

公开(公告)日：2024-09-05

申请号：US18661227

申请日：2024-05-10

Applicant: Covidien LP

Inventor： Alan M. Twomey ,  Shawn Phillips ,  Wanda F. Dent ,  Nathan K. Weidenhamer ,  Brandon Phan ,  Noah Johnson

IPC: A61B17/221 ,  A61B17/00 ,  A61B17/22 ,  A61F2/91

CPC classification number: A61B17/221 ,  A61F2/91 ,  A61B2017/00893 ,  A61B2017/22038 ,  A61F2210/0014

Abstract: In some examples, a thrombus removal device includes an elongated support member and an expandable element configured to segment the thrombus into smaller pieces as the thrombus moves into a basket defined by the expandable element. The expandable element is configured to expand radially outward from a delivery configuration to a deployed configuration. In the deployed configuration, the expandable element defines a proximal mouth configured to receive a thrombus and a distal basket configured to receive at least part of the thrombus after it has moved through the proximal mouth. A proximal portion of the expandable element defines a plurality of arms configured to segment the thrombus into smaller pieces.

公开(公告)号：US12059163B2

公开(公告)日：2024-08-13

申请号：US17079483

申请日：2020-10-25

Applicant: NeuroVasc Technologies, Inc.

Inventor： Jianlu Ma

IPC: A61B17/221 ,  A61B17/00 ,  A61B17/12 ,  A61B17/22 ,  A61F2/01 ,  A61M25/00 ,  A61B90/00

CPC classification number: A61B17/221 ,  A61B17/12109 ,  A61B17/12131 ,  A61F2/013 ,  A61M25/0021 ,  A61B2017/00867 ,  A61B2017/00893 ,  A61B2017/1205 ,  A61B2017/22038 ,  A61B2017/22079 ,  A61B2017/2212 ,  A61B2017/2215 ,  A61B2017/2217 ,  A61B90/39 ,  A61B2090/3966 ,  A61F2002/016 ,  A61F2230/0067 ,  A61M2025/0042

Abstract: A clot removal device has an expandable treatment member having a distal tip and a proximal end, a delivery wire having a distal end coupled to the proximal end of the expandable treatment member, and a flow restrictor carried along the delivery wire at a location that is separate and proximal from the expandable treatment member. The flow restrictor has a body with a distal section and a proximal section, the distal section being covered and the proximal section being uncovered. The expandable treatment member is moveable relative to the flow restrictor, and can be retracted into the distal section.

公开(公告)号：US20240238011A1

公开(公告)日：2024-07-18

申请号：US18290251

申请日：2022-05-11

Applicant: EPI-MINDER PTY LTD

Inventor： John Michael Heasman ,  Rohan J. Hoare ,  Tracy Lee Cameron

IPC: A61B17/34 ,  A61B17/00 ,  A61N1/05

CPC classification number: A61B17/3468 ,  A61B17/3417 ,  A61N1/0504 ,  A61B2017/00893 ,  A61B2017/3413 ,  A61B2017/3454 ,  A61B2017/3456

Abstract: A surgical tunneling tool and a method of using the surgical tunneling tool are disclosed. In one embodiment, the surgical tunneling tool includes a flexible shaft including a lumen through which an anesthetic may be delivered subcutaneously. In another embodiment, the surgical tunneling tool includes a sheath disposed on a flexible shaft, the sheath including at least one channel through which an anesthetic may be delivered subcutaneously. The subcutaneous distribution of anesthetic may involve stepwise insertion of the surgical tunneling tool. The surgical tunneling tool may be used for insertion of a medical device into a patient after use of the surgical tunneling tool to anesthetize a subcutaneous pathway for the medical device.

公开(公告)号：US20240237986A1

公开(公告)日：2024-07-18

申请号：US18457034

申请日：2023-08-28

Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM

Inventor： F. Javier OTERO ,  Joseph J. BEAMAN ,  Krishnendu ROY ,  Andrew ZIMBROFF

IPC: A61B17/12 ,  A61L27/18 ,  A61B17/00 ,  A61B90/00

CPC classification number: A61B17/12122 ,  A61B17/12186 ,  A61B17/1219 ,  A61L27/18 ,  A61B2017/00004 ,  A61B17/00491 ,  A61B17/0057 ,  A61B2017/00893 ,  A61B2017/00898 ,  A61B2090/3966 ,  A61L2400/06 ,  A61L2430/36

Abstract: Provided herein are methods, compositions, and devices for occluding cavities or passageways in a patient, in particular cavities or passageways in the cardiovascular system of a patient, such as the LAA of a patient's heart. The methods, compositions, and devices can be used to percutaneously occlude the LAA, decreasing the risk of thromboembolic events associated with AF.

公开(公告)号：US12029755B2

公开(公告)日：2024-07-09

申请号：US17535080

申请日：2021-11-24

Applicant: THE REGENTS OF THE UNIVERSITY OF MICHIGAN

Inventor： Yogendra Kanthi ,  David J. Pinsky

IPC: A61K33/00 ,  A61K9/00 ,  A61K33/24 ,  A61K45/06 ,  A61L27/02 ,  A61L27/18 ,  A61L27/34 ,  A61L27/54 ,  A61L27/58 ,  A61L29/06 ,  A61L29/16 ,  A61L31/02 ,  A61L31/06 ,  A61L31/10 ,  A61L31/14 ,  A61L31/16 ,  A61P9/00 ,  A61B17/00 ,  A61B17/12 ,  A61F2/01 ,  A61K9/127 ,  A61K9/51 ,  A61M1/16 ,  A61M1/36 ,  A61M60/148

CPC classification number: A61K33/00 ,  A61K9/0073 ,  A61K33/24 ,  A61K45/06 ,  A61L27/025 ,  A61L27/18 ,  A61L27/34 ,  A61L27/54 ,  A61L27/58 ,  A61L29/06 ,  A61L29/16 ,  A61L31/028 ,  A61L31/06 ,  A61L31/10 ,  A61L31/148 ,  A61L31/16 ,  A61P9/00 ,  A61B2017/00575 ,  A61B2017/00893 ,  A61B17/12022 ,  A61B17/12122 ,  A61F2/01 ,  A61K9/0024 ,  A61K9/127 ,  A61K9/5153 ,  A61M1/1698 ,  A61M1/3666 ,  A61M60/148 ,  A61M2202/0233 ,  A61K33/00 ,  A61K2300/00 ,  A61K33/24 ,  A61K2300/00 ,  A61L31/06 ,  C08L67/04 ,  A61L29/06 ,  C08L67/04

Abstract: Disclosed herein are methods of treating venous thrombosis and vascular inflammation through administration of carbon monoxide and/or a carbon monoxide releasing molecule. Also disclosed herein are devices capable of releasing carbon monoxide for the purpose of treating microvascular, arterial and venous thromboembolism and/or inflammation.

公开(公告)号：US20240206880A1

公开(公告)日：2024-06-27

申请号：US18596258

申请日：2024-03-05

Applicant: Coherex Medical, Inc.

Inventor： Daryl R. Edmiston ,  Clark C. Davis ,  Scott D. Miles

IPC: A61B17/12 ,  A61B17/00 ,  A61B90/00 ,  A61F2/01 ,  A61M5/00

CPC classification number: A61B17/12122 ,  A61B17/0057 ,  A61B17/12022 ,  A61B17/12172 ,  A61B17/12177 ,  A61B2017/00575 ,  A61B2017/00597 ,  A61B2017/00893 ,  A61B2017/00942 ,  A61B2017/12004 ,  A61B2017/1205 ,  A61B2017/12054 ,  A61B2017/12095 ,  A61B2090/3966 ,  A61F2/011 ,  A61F2002/016 ,  A61F2210/0014 ,  A61F2220/0016 ,  A61F2250/0067 ,  A61M5/007

Abstract: Devices, methods and systems are provided for occluding an opening within the tissue of a body, such as a left atrial appendage. In one embodiment, a medical device includes an occluder portion and an anchor portion. The occluder portion includes a hub that defines an axis, the occluder portion extending between a proximal end coupled to the hub and a distal end defining an occluder eyelet adjacent thereto. The anchor portion extends between a first end and a second end, the first end coupled to an anchor hub and the second end defining an anchor eyelet adjacent thereto and hingeably coupled to the occluder eyelet. With this arrangement, the anchor hub is moveable along the axis to move the anchor portion between a retracted position and a deployed position upon the occluder portion being in an expanded position.

公开(公告)号：US20240148419A1

公开(公告)日：2024-05-09

申请号：US18549123

申请日：2022-03-11

Applicant: I. CERAM

Inventor： André KERISIT ,  François BERTIN ,  Jérémy TRICARD

IPC: A61B17/80 ,  A61B17/00

CPC classification number: A61B17/8076 ,  A61B2017/00836 ,  A61B2017/0088 ,  A61B2017/00889 ,  A61B2017/00893

Abstract: The invention relates to a sternal reconstruction interface (100) comprising an elongate rectilinear body (101). The sternal reconstruction interface (100) comprises two protruding parts (102A, 102B) extending on either side along the elongate rectilinear body (101), each protruding part (102A, 102B) comprising a bevel, the protruding parts (102A, 102B) extending on one and the same plane along the entire length of the elongate rectilinear body (101), and fixing means (104) comprising at least two through-holes (104).

公开(公告)号：US11963766B2

公开(公告)日：2024-04-23

申请号：US16869880

申请日：2020-05-08

Applicant: Utah Valley University Foundation, Inc.

Inventor： Timothy Edwin Doyle ,  Natalie Charlotte Sullivan

IPC: A61B5/1473 ,  A61B5/291 ,  A61B10/02 ,  A61F2/04 ,  A61F2/38 ,  A61F13/00 ,  A61L31/10 ,  A61L31/16 ,  A61M25/00 ,  A61N1/05 ,  A61N1/362 ,  C23C14/22 ,  A61B5/1486 ,  A61B17/00 ,  A61B17/14 ,  A61B17/16 ,  A61B17/28 ,  A61B17/3201 ,  A61B17/3211 ,  A61F2/30 ,  A61M5/142 ,  A61M5/32

CPC classification number: A61B5/1473 ,  A61B5/291 ,  A61B10/0233 ,  A61F2/04 ,  A61F2/38 ,  A61F13/00063 ,  A61L31/10 ,  A61L31/16 ,  A61M25/0043 ,  A61N1/0534 ,  A61N1/0536 ,  A61N1/362 ,  A61N1/3629 ,  C23C14/22 ,  A61B5/14865 ,  A61B10/0275 ,  A61B2017/00022 ,  A61B2017/00039 ,  A61B2017/00526 ,  A61B2017/00884 ,  A61B2017/00889 ,  A61B2017/00893 ,  A61B2017/00938 ,  A61B2017/00942 ,  A61B17/14 ,  A61B17/1615 ,  A61B17/28 ,  A61B17/3201 ,  A61B17/3211 ,  A61B2562/0285 ,  A61F2002/30677 ,  A61L2300/252 ,  A61L2300/418 ,  A61L2400/18 ,  A61L2420/02 ,  A61M5/14248 ,  A61M5/32 ,  A61M2025/0057 ,  A61M2205/0244 ,  A61M2207/10

Abstract: An apparatus and method are disclosed for a biofunctional molecular imprint medical device configured to remain in permanent or temporary contact with a body comprising a supportive structure, a surface material that receives and retains a molecular imprint and that is positioned to contact a body tissue or other substance during use, a molecular imprint of a bioactive molecule wherein an imprinted cavity is of a bioactive molecule that catalyzes the promotion or suppression biological processes and at least one of a semiconductor, a nanoparticle quantum dot, a nano-island, and a quantum wire, wherein the nanoparticle quantum dot, nano-island, or quantum wire produces an electron wave function configuration that dynamically reconfigures the electron charge distribution within the molecular imprint, enabling tuning of the imprinted cavity.

公开(公告)号：US11937809B2

公开(公告)日：2024-03-26

申请号：US17828261

申请日：2022-05-31

Applicant: Cilag GmbH International

Inventor： Frederick E. Shelton, IV ,  Tamara S. V. Widenhouse

IPC: A61B17/072 ,  A61B17/068 ,  A61B17/00 ,  A61B17/115

CPC classification number: A61B17/068 ,  A61B17/072 ,  A61B17/07207 ,  A61B17/07292 ,  A61B2017/00004 ,  A61B2017/0046 ,  A61B2017/00893 ,  A61B2017/00898 ,  A61B2017/00938 ,  A61B2017/00942 ,  A61B2017/07214 ,  A61B17/115

Abstract: Implantable materials for use with end effectors like surgical stapling devices, and methods for using the same, are generally provided. In some embodiments, adjunct materials for use with surgical staplers are provided. For example, a kit for stapling tissue is provided that can include a surgical stapler having an end effector. The end effector can have first and second jaws. The kit can include an adjunct material having hydrophobic surface regions and hydrophilic surface regions and the adjunct material can be configured to mate to at least one of the jaws of the end effector. Other implants, devices, and methods for surgical stapling are also provided.